MedPath

Effect of a unani formulation in the treatment of Shara (hives)

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: L509- Urticaria, unspecified
Registration Number
CTRI/2022/10/046562
Lead Sponsor
Department of Ilmul Advia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Clinically diagnosed patients of CU according to the 2018 EAACI/GA2LEN/EDF/WAO guideline

2. Patients willing to sign consent form for the study.

Exclusion Criteria

1. Patients less than 14 and more than 60 years of age.

2. concomitant skin disease.

3. Patients suffering from any other systemic diseases, pregnant and lactating women.

4. unwillingness or inability to fulfil the protocol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DECLINE IN WHEALS EPISODES AND ITCHING INTENSITYTimepoint: EVERY FORTNIGHT UPTO 6 WEEKS
Secondary Outcome Measures
NameTimeMethod
IMPROVEMENT IN OBJECTIVE PARAMETERS LIKE QoL QUESTIONNAIRE, UAS7 AND BLOOD REPORTSTimepoint: BEFORE AND AFTER STUDY
© Copyright 2025. All Rights Reserved by MedPath